MODIFIED RELEASE FORMULATIONS FOR OPROZOMIB

摘要

This disclosure features modified release pharmaceutical formulations (e.g., extended release pharmaceutical formulations; e.g., solid dosage forms, e.g., tablets) that are useful for the oral administration of oprozomib, or a pharmaceutically acceptable sait thereof, to a human or animal subject as well as methods of making and using the formulations.